Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Félix Muñoz

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Revista Medica De Chile|June 5, 2013
Internal medicine, art and science in the third millenniumFélix Muñoz C
Revista Medica De Chile|April 8, 2009
[A critical appraisal to "AUGE" health plan in Chile]Oscar Román, Félix Muñoz
Revista Medica De Chile|December 13, 2005
[Reflections on evidence-based medicine]Félix Muñoz, Fernando Cabrera
Plos One|October 21, 2021
A model for predicting court decisions on child custodyJosé Félix Muñoz Soro, Carlos Serrano-Cinca
Cirugia Y Cirujanos|December 17, 2016
[Aplasia cutis congenita associated with epidermolysis bullosa]Félix Muñoz-Guerrero, Adrián Antonio Muñoz-Solís, José Manuel Ornelas-Aguirre
Tumori|June 6, 2015
Neutropenia secondary to exposure to levetiracetamMa Teresa Taberner Bonastre, Sergio Peralta Muñoz, Félix Muñoz Boza, et al.
Nature Communications|April 20, 2026
Improved dynamic MRI of the wrist and heart at 0.55 T enabled by rapid 3D printed flexible coilsFélix Muñoz, Ye Tian, Ted Lê, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 27, 2022
Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)Jorge Aparicio, Anna C Virgili Manrique, Jaume Capdevila, et al.
Cancers|December 11, 2022
Utility of ctDNA Liquid Biopsies from Cancer Patients: An Institutional Study of 285 ctDNA SamplesJosep Gumà, Karla Peña, Francesc Riu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Revista Medica De Chile|June 5, 2013
Internal medicine, art and science in the third millenniumFélix Muñoz C
Revista Medica De Chile|April 8, 2009
[A critical appraisal to "AUGE" health plan in Chile]Oscar Román, Félix Muñoz
Revista Medica De Chile|December 13, 2005
[Reflections on evidence-based medicine]Félix Muñoz, Fernando Cabrera
Plos One|October 21, 2021
A model for predicting court decisions on child custodyJosé Félix Muñoz Soro, Carlos Serrano-Cinca
Cirugia Y Cirujanos|December 17, 2016
[Aplasia cutis congenita associated with epidermolysis bullosa]Félix Muñoz-Guerrero, Adrián Antonio Muñoz-Solís, José Manuel Ornelas-Aguirre
Tumori|June 6, 2015
Neutropenia secondary to exposure to levetiracetamMa Teresa Taberner Bonastre, Sergio Peralta Muñoz, Félix Muñoz Boza, et al.
Nature Communications|April 20, 2026
Improved dynamic MRI of the wrist and heart at 0.55 T enabled by rapid 3D printed flexible coilsFélix Muñoz, Ye Tian, Ted Lê, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 27, 2022
Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)Jorge Aparicio, Anna C Virgili Manrique, Jaume Capdevila, et al.
Cancers|December 11, 2022
Utility of ctDNA Liquid Biopsies from Cancer Patients: An Institutional Study of 285 ctDNA SamplesJosep Gumà, Karla Peña, Francesc Riu, et al.
Pageof 1